Document is current
Any future updates will be listed below
-
Authors
Moon, Ji Eun
Lee, Yu Na
Jeong, Sehui
Jun, Hye Ryeong
Hoang, Minh Hien
Jo, Yeonggwon
Jang, Jinah
Shim, In Kyong https://orcid.org/0000-0002-1408-9048
Kim, Song Cheol
-
Funding
Funding for this research was provided by:
Ministry of Education, Science and Technology (No. 2021R1I1A2048392)
Ministry of Trade, Industry and Energy (20012378)
Ministry of Health and Welfare (RS-2022-00080258)
Asan Institute for Life Sciences, Asan Medical Center (2021IP0083-1)
- License Information
-
More Information
Article History
Received: 25 March 2024
Accepted: 1 October 2024
First Online: 23 October 2024
Declarations
:
: Induced pluripotent stem cells (iPSCs) were provided by the Center for Stem Cell Research, Asan Medical Center, Seoul, Korea, with ethical clearance from the Institutional Review Board (IRB: 2017 − 0503) granted on April 28, 2017, for the project titled “Development of Insulin-Producing Cells Differentiated from Embryonic Stem Cells and Induced Pluripotent Stem Cells.”
: Not applicable.
: All authors declare no potential conflict of interest. The authors declare that there are no other financial or non-financial competing interests. The authors of the article do not have any commercial association (e.g., consultancies, stock ownership, equity interests, patent-licensing arrangements) that might pose a conflict of interest in connection with the submitted article.
